United States · FDA National Drug Code directory
Edaravone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0781-3527_ae940bc6-1e6a-4b76-825c-bd2e1925e39a
- Product NDC
- 0781-3527
- Form
- INJECTION
- Composition / generic term
- Edaravone
- Labeler
- Sandoz Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250121
- Source listing expiry
- 20261231
Source-listed ingredients
- EDARAVONE — 30 mg/100mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 BAG in 1 CARTON (0781-3527-20) / 100 mL in 1 BAG (0781-3527-94) · 0781-3527-20
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →